JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, M.-K.
Right arrow Articles by Alkon, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, M.-K.
Right arrow Articles by Alkon, D. L.

Vol. 300, Issue 2, 408-416, February 2002

Pharmacological Protection of Synaptic Function, Spatial Learning, and Memory from Transient Hypoxia in Rats

Miao-Kun Sun, Hui Xu and Daniel L. Alkon

Blânchette Rockefeller Neurosciences Institute, Rockville, Maryland; and Laboratory of Adaptive Systems, National Institute of Neurological Disorders and Stroke/National Institutes of Health, Bethesda, Maryland

Hypoxia significantly reduced cholinergic theta  activity in rat CA1 field and intracellular theta  in the CA1 pyramidal cells, recorded in hippocampal slices. The hypoxic responses of the hippocampal CA1 pyramidal cells to a brief hypoxia consisted of a short period of "synaptic arrest", observed as an elimination of excitatory postsynaptic current under voltage clamp and recovered immediately as oxygenation was reinitiated. The hypoxic synaptic arrest was not associated with reduced postsynaptic responses of the pyramidal cells to externally applied L-glutamate, suggesting that the synaptic arrest might result from a presynaptic mechanism. The hypoxic synaptic arrest was abolished in the presence of 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), a specific adenosine A1 receptor antagonist. Blocking adenosine A1 receptors also eliminated effects of hypoxia on the hippocampal CA1 field theta  activity and intracellular theta  of the CA1 pyramidal cells. In behaving rats, brief hypoxia impaired their water maze performance in both the escape latency and probe tests. The impairment was prevented by intralateral cerebroventricular injections of DPCPX. These results suggest that hypoxia releases adenosine and produces an inhibition of synaptic transmission and intracellular signal cascade(s) involved in generation/maintenance of hippocampal CA1 theta  activity. This protection of synaptic efficacy and spatial learning through adenosine A1 receptor antagonism may represent an effective therapeutic strategy to eliminate functional interruption due to transient hypoxic episodes and/or chronic hypoxia secondary to compromise of respiratory function.


0022-3565/02/3002-0408$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Anesth. Analg.Home page
A. Bekker, M. Haile, K. Gingrich, L. Wenning, A. Gorny, D. Quartermain, and T. Blanck
Physostigmine Reverses Cognitive Dysfunction Caused by Moderate Hypoxia in Adult Mice
Anesth. Analg., September 1, 2007; 105(3): 739 - 743.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. F. Bruggemans, A. van Boxtel, and H. A. Huysmans
INVITED COMMENTARY
Ann. Thorac. Surg., April 1, 2005; 79(4): 1314 - 1315.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.